title: Duration and magnitude of hypotension and monocyte deactivation in patients with community-acquired pneumonia.
abstract: The objective was to examine the relationship of duration and magnitude of arterial hypotension to subsequent cellular immune suppression and cytokinemia in patients hospitalized with community-acquired pneumonia (CAP). We studied an observational cohort of 525 subjects hospitalized after presenting to the emergency department with radiographic and clinical signs of CAP. We compared the duration and magnitude of hypotension, using the cardiovascular Sequential Organ Failure Assessment (CV SOFA) subscore, to day 3 monocyte expression of human leukocyte antigen-DR (mHLA-DR), a previously validated marker of cellular immune suppression. A significant association of CV SOFA with decreased mHLA-DR expression was present in univariate analysis (P < 0.001) and persisted after adjustment for illness severity and other covariates (P = 0.01). With CV SOFA separated into components of magnitude and duration, after covariate adjustment, only duration was associated with day 3 mHLA-DR expression (P = 0.03). Levels of key proinflammatory and anti-inflammatory cytokines (interleukin 6 [IL-6], IL-10, tumor necrosis factor) increased with hypotension exposure and were also associated with mHLA-DR expression. In patients admitted with CAP, arterial hypotension over the first 3 days is associated with markers of monocyte deactivation. The duration of exposure to hypotension may be more important than the magnitude, and monocyte deactivation correlates with IL-6 and IL-10 release. These results suggest that persistent hypotension might contribute to immunosuppression following septic shock.
authors.affiliation: Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, Department of Critical Care Medicine, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA.
authors.forename: Peter M
authors.initials: PM
authors.lastname: Simon
authors.forename: Russell L
authors.initials: RL
authors.lastname: Delude
authors.forename: MinJae
authors.initials: M
authors.lastname: Lee
authors.forename: Lan
authors.initials: L
authors.lastname: Kong
authors.forename: Lynda J
authors.initials: LJ
authors.lastname: Guzik
authors.forename: David T
authors.initials: DT
authors.lastname: Huang
authors.forename: Derek C
authors.initials: DC
authors.lastname: Angus
authors.forename: John A
authors.initials: JA
authors.lastname: Kellum
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D017714:Community-Acquired Infections / Q000150:complications* / Q000276:immunology*; D005260:Female; D005434:Flow Cytometry; D006684:HLA-DR Antigens / Q000276:immunology; D006801:Humans; D007022:Hypotension / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000276:immunology*; D011014:Pneumonia / Q000150:complications* / Q000276:immunology*; D012772:Shock, Septic / Q000276:immunology
chemical_list: D006684:HLA-DR Antigens
references.citation: Transpl Infect Dis. 1999 Sep;1(3):146-52
references.pmid: 11428984
references.citation: Crit Care. 2004 Apr;8(2):R82-90
references.pmid: 15025782
references.citation: J Surg Res. 1989 Jun;46(6):553-6
references.pmid: 2733418
references.citation: Crit Care. 2010;14(1):R15
references.pmid: 20144219
references.citation: Nat Med. 2009 May;15(5):496-7
references.pmid: 19424209
references.citation: J Leukoc Biol. 2005 Aug;78(2):325-37
references.pmid: 15817707
references.citation: Arch Surg. 1987 Jan;122(1):62-8
references.pmid: 3800651
references.citation: Arch Intern Med. 2007 Aug 13-27;167(15):1655-63
references.pmid: 17698689
references.citation: Scand J Infect Dis. 2007;39(6-7):596-603
references.pmid: 17577824
references.citation: Crit Care Med. 2001 Jul;29(7):1303-10
references.pmid: 11445675
references.citation: N Engl J Med. 1997 Jan 23;336(4):243-50
references.pmid: 8995086
references.citation: Clin Diagn Lab Immunol. 2004 Jan;11(1):161-7
references.pmid: 14715564
references.citation: Intensive Care Med. 2003 Mar;29(3):368-77
references.pmid: 12536269
references.citation: Intensive Care Med. 2006 Aug;32(8):1175-83
references.pmid: 16741700
references.citation: Intensive Care Med. 2000 Jul;26(7):883-92
references.pmid: 10990102
references.citation: Immunol Lett. 2004 Sep;95(2):193-8
references.pmid: 15388260
references.citation: Arch Surg. 1992 Jan;127(1):70-5; discussion 75-6
references.pmid: 1734852
references.citation: Am J Physiol. 1990 Oct;259(4 Pt 2):R663-78
references.pmid: 2145776
references.citation: Arch Surg. 2002 Sep;137(9):1037-43; discussion 1043
references.pmid: 12215155
references.citation: Clin Chem. 2005 Dec;51(12):2341-7
references.pmid: 16214828
references.citation: Crit Care Med. 2009 Jun;37(6):1850-7
references.pmid: 19384219
references.citation: Crit Care Med. 1998 Nov;26(11):1793-800
references.pmid: 9824069
references.citation: J Immunol. 2006 Aug 1;177(3):1941-55
references.pmid: 16849508
references.citation: J Immunol. 1996 Dec 15;157(12):5748-54
references.pmid: 8955229
references.citation: Cell. 2003 Mar 7;112(5):645-57
references.pmid: 12628185
references.citation: J Endotoxin Res. 2005;11(5):311-20
references.pmid: 16263005
references.citation: Med Res Rev. 1996 Jan;16(1):87-109
references.pmid: 8788215
references.citation: Crit Care Med. 2002 May;30(5):1015-23
references.pmid: 12006796
references.citation: JAMA. 2001 Oct 10;286(14):1754-8
references.pmid: 11594901
references.citation: Crit Care Med. 2001 Apr;29(4):880-6
references.pmid: 11373487
references.citation: Crit Care. 2004 Dec;8(6):485-91
references.pmid: 15566620
references.citation: Surg Gynecol Obstet. 1989 Feb;168(2):138-42
references.pmid: 2911791
references.citation: Diagn Pathol. 2009 Apr 16;4:12
references.pmid: 19371402
references.citation: Mol Med. 2008 Jan-Feb;14(1-2):64-78
references.pmid: 18026569